Additionally, the V158F polymorphism within the FCGR3A gene has been identified as a potential predictor of outcomes in bone marrow transplantation, with the V/V genotype associated with a reduced risk of both acute and chronic GVHD as well as improved overall survival rate (45). This evidence concerns the gene FCGR3A and chronic graft versus host disease.